Investigational new drugThyroid Analog
Compound 61492
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061492
Risk Class
MODERATE
Last Audit
Mar 7, 2108
Research Abstract
Thyroid Analog candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61492 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061492 with updates logged 2108-03-07.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61492Thyroid Analog Program 61492
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061492
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61492